<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01611220</url>
  </required_header>
  <id_info>
    <org_study_id>USL22#03/12-CEP329</org_study_id>
    <nct_id>NCT01611220</nct_id>
  </id_info>
  <brief_title>Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa</brief_title>
  <acronym>RePAN</acronym>
  <official_title>Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Villa Garda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Villa Garda Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anorexia Nervosa inpatient treatment has often a short-term success as weight is restored to&#xD;
      a healthy level, but high percentage of patients relapse during the first year following the&#xD;
      discharge. The development of strategies to overcome this problem represents a priority for&#xD;
      clinicians. Aim of this trial is to evaluate the effects of a relapse prevention program&#xD;
      based on cognitive dissonance theory developed for hospitalized patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inpatient treatment for anorexia nervosa is often successful in restoring body weight, but a&#xD;
      high percentage of patients relapse following discharge. The aim of the study was to assess&#xD;
      the effect of a relapse prevention program during the last phase of inpatient treatment.&#xD;
      Patients, when they achieve a BMI of 18.5, are randomly allocated to complete the standard&#xD;
      cognitive behavior inpatient treatment (CBT-I) or to complete the standard CBT-I plus eight&#xD;
      relapse prevention groups based on the cognitive dissonance. The intervention has been&#xD;
      derived by the selective and indicated prevention programs using a dissonance-based approach.&#xD;
      This intervention showed to be effective in reducing the risk for eating pathology onset. The&#xD;
      primary outcome of the study is to assess the number of patients allocated to the two&#xD;
      condition with a BMI equal or greater than 18.5 at 12-months after discharge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>1 year</time_frame>
    <description>The main outcome is to assess the number of patients with good BMI outcome (BMI ≥ 18.5) at 12-month follow-up end in the two arm conditions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eating disorder Examination (EDE)</measure>
    <time_frame>1 year</time_frame>
    <description>Number of patients with &quot;full remission&quot; defined as having a global EDE score below 1SD above the community mean (1.74) and a BMI ≥ 18.5.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard cognitive behavior inpatient treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RePAN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard cognitive behavior inpatient treatment plus 8 dissonance relapse prevention groups</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>RePAN</intervention_name>
    <description>The dissonance relapse prevention intervention consists of eight groups conducted by a psychologist who involves participants in interactive activities aimed to prevent relapse after discharge from the inpatient treatment</description>
    <arm_group_label>RePAN</arm_group_label>
    <other_name>Dissonance relapse prevention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Body Mass Index ≥ 18.5&#xD;
&#xD;
          -  Anorexia Nervosa patients admitted to inpatient treatment&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male&#xD;
&#xD;
          -  Schizophrenia or other psychiatric disorders&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Medical complication that may hamper the interpretation of results (medical condition&#xD;
             that causes weight changes)&#xD;
&#xD;
          -  Absence of medical treatment (drugs) that may hamper the interpretation of results&#xD;
&#xD;
          -  Pregnancy or plan to get pregnant&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Riccardo Dalle Grave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Eating and Weight Disorders, Villa Garda Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Villa Garda Hospital</name>
      <address>
        <city>Garda</city>
        <state>Verona</state>
        <zip>37016</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008 Apr;76(2):329-40. doi: 10.1037/0022-006X.76.2.329.</citation>
    <PMID>18377128</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 25, 2012</study_first_submitted>
  <study_first_submitted_qc>May 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 4, 2012</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Villa Garda Hospital</investigator_affiliation>
    <investigator_full_name>Riccardo Dalle Grave</investigator_full_name>
    <investigator_title>Head of Department of Eating and Weight Disorders</investigator_title>
  </responsible_party>
  <keyword>Anorexia Nervosa</keyword>
  <keyword>Relapse prevention</keyword>
  <keyword>Cognitive Dissonance</keyword>
  <keyword>Inpatient treatment</keyword>
  <keyword>Cognitive behavior therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

